Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05812352 · ClinicalTrials.gov registry record · NA

Supporting Laypeople Addressing Prehospital Hemorrhage Study

A NA study, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
205
Enrollment target

NCT05812352: Completed NA study, sponsored by University of Michigan.

NCT05812352 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 205 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05812352, a NA study, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
205 participants
Enrollment target

Study Summary

It is unknown if bystanders equipped with point-of-care (POC) instruction are as effective as bystanders with in-person training for bleeding control. Therefore, POC instructional interventions were developed during this study in response to the scalability challenges associated with in-person training to measure the comparative effectiveness and skill retention of POC instructions vs in-person training using a randomized clinical trial design.

Primary Outcome

Number of participants who meet all criteria for correct application of the tourniquet

Interventions

  • BEHAVIORAL Audio kit
  • BEHAVIORAL Instructional flashcard
  • BEHAVIORAL In-person training

Trial Details

FieldValue
Enrollment Target 205 participants
Start Date 2023-01-24
Est. Completion 2023-12-01
Phase NA
University of Michigan

1,327 total trials

What the finished NCT05812352 record still lists

NCT05812352 is an interventional study that assigns participants to a tested intervention. The registered 205 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).

The record links to 0 conditions, and to 3 interventions - of which Audio kit is the first listed.

NCT05812352 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05812352 about?

NCT05812352 is a clinical study titled "Supporting Laypeople Addressing Prehospital Hemorrhage Study". It is unknown if bystanders equipped with point-of-care (POC) instruction are as effective as bystanders with in-person training for bleeding control. Therefore, POC instructional interventions were developed during this study in response to the scalability challenges associated with in-person train...

What is the current status of trial NCT05812352?

This trial is currently completed. It is a NA study. The enrollment target is 205 participants. The study started on 2023-01-24. Estimated completion is 2023-12-01.

What interventions are being tested in trial NCT05812352?

The interventions under investigation include: Audio kit (BEHAVIORAL), Instructional flashcard (BEHAVIORAL), In-person training (BEHAVIORAL).

Who is sponsoring clinical trial NCT05812352?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05812352's enrollment target sits among peer trials

205 499th of 2000 higher than 1,501 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03457493 · 205 participants · Phase 1

    The University of Alabama At Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy

  • NCT05134857 · 205 participants · Phase 2

    The Zonisamide and Reinforcement for Reducing Alcohol Use (ZARRA) Study

  • NCT05181891 · 205 participants · Phase 2

    Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking

  • NCT05283811 · 205 participants · NA

    Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy Patients

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05812352, the US trial registry maintained by the National Library of Medicine. NCT05812352 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.